Index Investing News
Tuesday, April 14, 2026
No Result
View All Result
  • Login
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
No Result
View All Result
Index Investing News
No Result
View All Result

India defends cough syrups linked to Gambia child deaths

by Index Investing News
December 16, 2022
in World
Reading Time: 3 mins read
A A
2
Home World
Share on FacebookShare on Twitter


The WHO had advised regulators to stop the sale of the four Indian-made cough syrups

India has said that four cough syrups linked to child deaths in the Gambia were found to be complying with safety specifications when tested at home.

The WHO had said in October that the four syrups – made by India’s Maiden Pharmaceuticals – may be linked to the deaths of at least 66 children.

But India’s drug regulator said in a letter that the WHO has not provided any evidence yet.

India is a major supplier of generic drugs to Africa.

The letter, dated 13 December, was written by Dr VG Somani, India’s drugs controller general, and addressed to Rogerio Gaspar, director of regulation and prequalification at the WHO.

India had said in October that it was investigating the cough syrups after the WHO issued an alert.

The WHO said it had tested samples of the syrups – Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup – and found that they contained “unacceptable amounts of diethylene glycol and ethylene glycol as contaminants”.

Diethylene glycol and ethylene glycol are toxic to humans and could be fatal if consumed.

But in his letter, Dr Somani said that the samples it tested at a government laboratory “were found not to have been contaminated” with the compounds. The junior minister for chemicals and fertilisers, Bhagwanth Khuba, also told Parliament this week that the cough syrup samples “were declared to be of standard quality” by a government analyst at the Regional Drug Testing Laboratory in Chandigarh.

The test results are being further examined by a panel of Indian experts.

Dr Somani added that the panel had also requested “specific information” from the WHO on “further details essential to establish the causality” but had not received this yet. The letter did not specify what information the committee had asked for.

When contacted, Dr Somani’s office asked the BBC to get in touch with India’s health ministry. The BBC has emailed the ministry and the WHO for comment.

A senior adviser to India’s information and broadcasting ministry told the BBC that the WHO had been “presumptuous” in blaming the cough syrups for the deaths of the children.

“Subsequent inspections, tests and studies by Government of India’s notified bodies and technical team have shown that WHO’s presumptuous statement was untrue and incorrect,” said Kanchan Gupta, adding that the WHO had “[jumped] the gun without valid scientific reasons”.

The WHO’s intervention came after medical authorities in The Gambia detected an increase in cases of acute kidney injury among children under the age of five in late July. The government later said around 69 children had died from these injuries.

But a representative of The Gambia’s national regulator said in late October that it had not yet confirmed whether the medicines were responsible for the deaths.

“We haven’t concluded yet it is the medicine that caused it. A good number of kids died without taking any medications,” Tijan Fallow said, according to Reuters.

Read more India stories from the BBC:



Source link

Tags: ChildcoughdeathsdefendsGambiaIndiaLinkedsyrups
ShareTweetShareShare
Previous Post

Upcoming Budget to follow spirit of earlier editions: Finance Minister Sitharaman

Next Post

ACN Earnings: Key quarterly highlights from Accenture’s Q1 2023 financial results

Related Posts

New U.S. autonomous Squire Seaglider conducts test flight

New U.S. autonomous Squire Seaglider conducts test flight

by Index Investing News
April 13, 2026
0

Key PointsREGENT confirms successful ground-effect flight of its autonomous Squire defense Seaglider in the United States on April 13, 2026.Squire...

Can global supply chains recover from the Iran war? | US-Israel war on Iran

Can global supply chains recover from the Iran war? | US-Israel war on Iran

by Index Investing News
April 9, 2026
0

Conflict upends flow of critical raw materials for manufacturing, aviation and technology.The United States and Iran may have agreed to...

Artemis II crew will see total solar eclipse during moon flyby

Artemis II crew will see total solar eclipse during moon flyby

by Index Investing News
April 5, 2026
0

The crew is expected to lose contact with Earth for about 40 minutes Monday while they're behind the far side...

Protest shuts down ferry rides between Puerto Rico and Vieques, snarling travel plans

Protest shuts down ferry rides between Puerto Rico and Vieques, snarling travel plans

by Index Investing News
April 1, 2026
0

SAN JUAN, Puerto Rico -- A protest over a rate increase forced Puerto Rico’s government on Wednesday to cancel ferry...

Were 2 enough? Experts question number of air traffic controllers during LaGuardia midnight shift

Were 2 enough? Experts question number of air traffic controllers during LaGuardia midnight shift

by Index Investing News
March 28, 2026
0

Were two air traffic controllers enough?Following the deadly collision between an Air Canada jet and a fire truck on the...

Next Post
ACN Earnings: Key quarterly highlights from Accenture’s Q1 2023 financial results

ACN Earnings: Key quarterly highlights from Accenture’s Q1 2023 financial results

The big money US military contractors are making in Ukraine’s war, explained by an invitation

The big money US military contractors are making in Ukraine’s war, explained by an invitation

RECOMMENDED

A “Soft Landing” Looks Shaky as Recession Risk Starts to Rise

A “Soft Landing” Looks Shaky as Recession Risk Starts to Rise

September 4, 2023
WMT, ADBE, CSCO, HE and more

WMT, ADBE, CSCO, HE and more

August 17, 2023
Can We Morally Assess Enterprise?

Can We Morally Assess Enterprise?

October 8, 2024
Exhilaration in battered Ukraine as coup arises in Russia

Exhilaration in battered Ukraine as coup arises in Russia

June 25, 2023
Just Listed | 1168 Sterling Pine Place

Just Listed | 1168 Sterling Pine Place

March 5, 2024
Dividend Aristocrats In Focus: A.O. Smith Company

Dividend Aristocrats In Focus: A.O. Smith Company

February 22, 2025
Bitcoin and Ethereum Charges Collapse: Transaction Prices Plunge Over 90% 12 months-on-12 months

Bitcoin and Ethereum Charges Collapse: Transaction Prices Plunge Over 90% 12 months-on-12 months

April 19, 2025
Should We Buy Shares of Mobileye Stock?

Should We Buy Shares of Mobileye Stock?

January 16, 2023
Index Investing News

Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.

  • 1717575246.7
  • Browse the latest news about investing and more
  • Contact us
  • Cookie Privacy Policy
  • Disclaimer
  • DMCA
  • Privacy Policy
  • Terms and Conditions
  • xtw18387b488

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In